Nomegestrol acetate
Modify Date: 2025-08-25 11:28:00
Nomegestrol acetate structure
|
Common Name | Nomegestrol acetate | ||
|---|---|---|---|---|
| CAS Number | 58652-20-3 | Molecular Weight | 370.482 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 507.3±50.0 °C at 760 mmHg | |
| Molecular Formula | C23H30O4 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 219.8±30.2 °C | |
| Symbol |
GHS08, GHS09 |
Signal Word | Warning | |
Use of Nomegestrol acetateNomegestrol acetate is a potent, highly selective progestogen, which is characterized as a full agonist at the progesterone receptor, with no or minimal binding to other steroid receptors, including the androgen and glucocorticoid receptors[1]. |
| Name | Nomegestrol acetate |
|---|---|
| Synonym | More Synonyms |
| Description | Nomegestrol acetate is a potent, highly selective progestogen, which is characterized as a full agonist at the progesterone receptor, with no or minimal binding to other steroid receptors, including the androgen and glucocorticoid receptors[1]. |
|---|---|
| Related Catalog | |
| Target |
Progesterone receptor[1] |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 507.3±50.0 °C at 760 mmHg |
| Molecular Formula | C23H30O4 |
| Molecular Weight | 370.482 |
| Flash Point | 219.8±30.2 °C |
| Exact Mass | 370.214417 |
| PSA | 60.44000 |
| LogP | 3.34 |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.554 |
| Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS08, GHS09 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H361fd-H400 |
| Precautionary Statements | P280 |
| Hazard Codes | N |
| Risk Phrases | 63-50 |
| Safety Phrases | 61 |
| RIDADR | UN 3077 9 / PGIII |
| RTECS | RC8899200 |
|
Changing convention in combination oral contraceptives: estradiol and nomegestrol acetate in a monophasic 24/4 regimen.
J. Fam. Plann. Reprod. Health Care 39(3) , 211-6, (2013) Initial oral contraceptive regimens were characterised by high doses of ethinylestradiol (EE) and a progestogen in a 21-day regimen that either included seven additional hormone-free tablets or simply... |
|
|
A new contraceptive pill containing 17β-estradiol and nomegestrol acetate.
Womens. Health (Lond. Engl.) 9(1) , 13-23, (2013) Most combined oral contraceptive pills contain ethinyl estradiol (EE) with progestins. In order to minimize the pill's cardiovascular risks, the concept of using 17β-estradiol (E2), the endogenous est... |
|
|
The “newer” progestogens and postmenopausal hormone therapy (HRT)
J. Steroid Biochem. Mol. Biol. 142 , 48-51, (2014) • The “newer” progestogens have a high bioavailability. • The “newer” progestogens have a sufficient progestogenic effect. • The “newer” progestogens do not cause undue side effects. • The “newer” pro... |
| [(8S,9S,10R,13S,14S,17R)-17-acetyl-6,13-dimethyl-3-oxo-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate |
| EINECS 261-379-8 |
| 6-Methyl-3,20-dioxo-19-norpregna-4,6-dien-17-yl acetate |
| Lutenyl |
| (17a)-17-Acetyl-6-methyl-3-oxoestra-4,6-dien-17-yl acetate |
| MFCD00941390 |
| 17-Acetoxy-6-methyl-19-norpregna-4,6-diene-3,20-dione |
| Nomegestrol acetate |
| Estra-4,6-dien-3-one, 17-acetyl-17-(acetyloxy)-6-methyl-, (17α)- |
| 19-normegestrol acetate |